Clinical trial · Observational
NovellusDx Tissue Collection Protocol
An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery
NCT01791322CI-TRIAL-00032279completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Patients Eligible for Tumor Biopsy | — | UNRESOLVED | — |
| Patients That Have Been Diagnosed With Colorectal Cancer | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Correct identification of tumor mutant genes
- timeFrame
- up to 12 month
- description
- Correct identification of tumor mutant genes, in over 85% of the cases
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Patients that have been diagnosed positive for colon cancer. * available treatment follow up during cancer treatment Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.